U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Product Details

Additional Information about Patents

  • Patent information is published on or after the submission date as defined in 21 CFR 314.53(d)(5).
  • Patent listings published prior to August 18, 2003, only identify method-of-use claims. The listed patents may include drug substance and/or drug product claims that are not indicated in the listing.
  • As of December 5, 2016, an NDA holder submitting information on a patent that claims both the drug substance and the drug product (and is eligible for listing on either basis) is required only to specify that it claims either the drug substance or the drug product. Orange Book users should not rely on an Orange Book patent listing, regardless of when first published, to determine the range of patent claims that may be asserted by an NDA holder or patent owner.

Patent and Exclusivity for: N202811

Product 002

Patent Data

Product No Patent No Patent Expiration Drug Substance Drug Product Patent Use Code Delist Requested Submission Date
002 7304036 08/30/2026 DS DP U-1278 U-1516
002 7371727 01/28/2024 DS
002 7704947 01/28/2024 DS DP
002 7745409 01/28/2024 DS DP
002 8080526 01/28/2024 DS DP
002 8110553 01/28/2024 U-1278
002 8748573 10/30/2031 U-1515 U-1516 06/11/2014
002 8802628 10/30/2031 DP 08/19/2014
002 8933030 02/17/2031 DP 02/06/2015
002 9708371 08/16/2033 DP U-1515 08/10/2017

Exclusivity Data

Product No Exclusivity Code Exclusivity Expiration



View a list of all patent use codes
View a list of all exclusivity codes

Back to Top